ELEV
Price
$0.36
Change
-$0.02 (-5.26%)
Updated
Jun 27 closing price
Capitalization
21.47M
38 days until earnings call
XBIO
Price
$3.53
Change
-$0.46 (-11.53%)
Updated
Jun 27 closing price
Capitalization
5.47M
Interact to see
Advertisement

ELEV vs XBIO

Header iconELEV vs XBIO Comparison
Open Charts ELEV vs XBIOBanner chart's image
Elevation Oncology
Price$0.36
Change-$0.02 (-5.26%)
Volume$7.91M
Capitalization21.47M
Xenetic Biosciences
Price$3.53
Change-$0.46 (-11.53%)
Volume$68.3K
Capitalization5.47M
ELEV vs XBIO Comparison Chart in %
Loading...
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELEV vs. XBIO commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELEV is a Hold and XBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ELEV: $0.36 vs. XBIO: $3.53)
Brand notoriety: ELEV and XBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELEV: 536% vs. XBIO: 87%
Market capitalization -- ELEV: $21.47M vs. XBIO: $5.47M
ELEV [@Biotechnology] is valued at $21.47M. XBIO’s [@Biotechnology] market capitalization is $5.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELEV’s FA Score shows that 1 FA rating(s) are green whileXBIO’s FA Score has 1 green FA rating(s).

  • ELEV’s FA Score: 1 green, 4 red.
  • XBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, XBIO is a better buy in the long-term than ELEV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELEV’s TA Score shows that 6 TA indicator(s) are bullish.

  • ELEV’s TA Score: 6 bullish, 4 bearish.

Price Growth

ELEV (@Biotechnology) experienced а -4.91% price change this week, while XBIO (@Biotechnology) price change was +26.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

ELEV is expected to report earnings on Aug 06, 2025.

XBIO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELEV($21.5M) has a higher market cap than XBIO($5.48M). XBIO YTD gains are higher at: -11.529 vs. ELEV (-35.603). XBIO has higher annual earnings (EBITDA): -3.88M vs. ELEV (-41.4M). ELEV has more cash in the bank: 80.7M vs. XBIO (5.16M). XBIO has less debt than ELEV: XBIO (153K) vs ELEV (31.3M). XBIO has higher revenues than ELEV: XBIO (2.58M) vs ELEV (0).
ELEVXBIOELEV / XBIO
Capitalization21.5M5.48M393%
EBITDA-41.4M-3.88M1,067%
Gain YTD-35.603-11.529309%
P/E RatioN/AN/A-
Revenue02.58M-
Total Cash80.7M5.16M1,563%
Total Debt31.3M153K20,458%
FUNDAMENTALS RATINGS
XBIO: Fundamental Ratings
XBIO
OUTLOOK RATING
1..100
97
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELEV
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 14 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SXC8.180.19
+2.38%
Suncoke Energy
MHO112.741.51
+1.36%
M/I Homes
AVB204.380.25
+0.12%
AvalonBay Communities
MYNZ1.38-0.02
-1.43%
Mainz Biomed N.V.
BFLY1.96-0.06
-2.97%
Butterfly Network

ELEV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELEV has been loosely correlated with TBPH. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ELEV jumps, then TBPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELEV
1D Price
Change %
ELEV100%
-5.90%
TBPH - ELEV
37%
Loosely correlated
+4.57%
BOLT - ELEV
31%
Poorly correlated
-2.43%
AUTL - ELEV
29%
Poorly correlated
N/A
ADAP - ELEV
29%
Poorly correlated
+1.16%
XBIO - ELEV
28%
Poorly correlated
-11.53%
More

XBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIO has been loosely correlated with SYRE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIO jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIO
1D Price
Change %
XBIO100%
-11.53%
SYRE - XBIO
34%
Loosely correlated
-4.99%
VXRT - XBIO
29%
Poorly correlated
-8.09%
CDTX - XBIO
28%
Poorly correlated
+2.96%
ELEV - XBIO
28%
Poorly correlated
-5.90%
AUTL - XBIO
27%
Poorly correlated
N/A
More